Ceredex Value Advisors’s MetLife MET Stock Holding History

Ceredex Value Advisors’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,429,828	Closed	-$65.6M	–	184
2018 Q1	$65.6M	Buy	+1,429,828	New	+$69.4M	0.78%	48

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ceredex Value Advisors's MET Position: Q2 2018 in Review

Ceredex Value Advisors sold out of MetLife (MET) in Q2 2018, closing a stake of 1,429,828 shares — an estimated $65.6M sold.

Ceredex Value Advisors first reported a position in MET in Q1 2018 and held it in 1 quarter. The position peaked at $65.6M in Q1 2018. 1,030 funds tracked by Wall St. Rank hold MET as of Q2 2018.

Ceredex Value Advisors reported no remaining MetLife position as of Q2 2018 after selling out during the quarter.
Ceredex Value Advisors sold 1,429,828 MetLife shares in Q2 2018, an estimated $65.6M.
Ceredex Value Advisors first reported a position in MetLife in Q1 2018 and held it in 1 quarter.
Ceredex Value Advisors's MetLife position peaked at $65.6M in Q1 2018.
1,030 funds tracked by Wall St. Rank held MetLife as of Q2 2018.

Based on Ceredex Value Advisors's 13F filing for Q2 2018, filed 13 Aug 2018.